118 related articles for article (PubMed ID: 31228326)
1. Aspartyl Aminopeptidase Suppresses Proliferation, Invasion, and Stemness of Breast Cancer Cells via Targeting CD44.
Geng N; Zhang W; Li Y; Li F
Anat Rec (Hoboken); 2019 Dec; 302(12):2178-2185. PubMed ID: 31228326
[TBL] [Abstract][Full Text] [Related]
2. A PAK5-DNPEP-USP4 axis dictates breast cancer growth and metastasis.
Geng N; Li Y; Zhang W; Wang F; Wang X; Jin Z; Xing Y; Li D; Zhang H; Li Y; Li X; Cheng M; Jin F; Li F
Int J Cancer; 2020 Feb; 146(4):1139-1151. PubMed ID: 31219614
[TBL] [Abstract][Full Text] [Related]
3. Unraveling the roles of CD44/CD24 and ALDH1 as cancer stem cell markers in tumorigenesis and metastasis.
Li W; Ma H; Zhang J; Zhu L; Wang C; Yang Y
Sci Rep; 2017 Oct; 7(1):13856. PubMed ID: 29062075
[TBL] [Abstract][Full Text] [Related]
4. Diallyl Disulfide Inhibits Breast Cancer Stem Cell Progression and Glucose Metabolism by Targeting CD44/PKM2/AMPK Signaling.
Xie X; Huang X; Tang H; Ye F; Yang L; Guo X; Tian Z; Xie X; Peng C; Xie X
Curr Cancer Drug Targets; 2018; 18(6):592-599. PubMed ID: 29110616
[TBL] [Abstract][Full Text] [Related]
5. SALL4 - KHDRBS3 network enhances stemness by modulating CD44 splicing in basal-like breast cancer.
Matsumoto Y; Itou J; Sato F; Toi M
Cancer Med; 2018 Feb; 7(2):454-462. PubMed ID: 29356399
[TBL] [Abstract][Full Text] [Related]
6. Predictive Value of CD44 in Muscle-Invasive Bladder Cancer and Its Relationship with IL-6 Signaling.
Wu CT; Lin WY; Chen WC; Chen MF
Ann Surg Oncol; 2018 Nov; 25(12):3518-3526. PubMed ID: 30128900
[TBL] [Abstract][Full Text] [Related]
7. Microenvironmental networks promote tumor heterogeneity and enrich for metastatic cancer stem-like cells in Luminal-A breast tumor cells.
Weitzenfeld P; Meshel T; Ben-Baruch A
Oncotarget; 2016 Dec; 7(49):81123-81143. PubMed ID: 27835603
[TBL] [Abstract][Full Text] [Related]
8. JMJD3 suppresses stem cell-like characteristics in breast cancer cells by downregulation of Oct4 independently of its demethylase activity.
Xun J; Wang D; Shen L; Gong J; Gao R; Du L; Chang A; Song X; Xiang R; Tan X
Oncotarget; 2017 Mar; 8(13):21918-21929. PubMed ID: 28423536
[TBL] [Abstract][Full Text] [Related]
9. CD44 Promotes PD-L1 Expression and Its Tumor-Intrinsic Function in Breast and Lung Cancers.
Kong T; Ahn R; Yang K; Zhu X; Fu Z; Morin G; Bramley R; Cliffe NC; Xue Y; Kuasne H; Li Q; Jung S; Gonzalez AV; Camilleri-Broet S; Guiot MC; Park M; Ursini-Siegel J; Huang S
Cancer Res; 2020 Feb; 80(3):444-457. PubMed ID: 31722999
[TBL] [Abstract][Full Text] [Related]
10. Chloride channel ClC-5 binds to aspartyl aminopeptidase to regulate renal albumin endocytosis.
Lee A; Slattery C; Nikolic-Paterson DJ; Hryciw DH; Wilk S; Wilk E; Zhang Y; Valova VA; Robinson PJ; Kelly DJ; Poronnik P
Am J Physiol Renal Physiol; 2015 Apr; 308(7):F784-92. PubMed ID: 25587118
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-199a targets CD44 to suppress the tumorigenicity and multidrug resistance of ovarian cancer-initiating cells.
Cheng W; Liu T; Wan X; Gao Y; Wang H
FEBS J; 2012 Jun; 279(11):2047-59. PubMed ID: 22498306
[TBL] [Abstract][Full Text] [Related]
12. Different Effects of BORIS/CTCFL on Stemness Gene Expression, Sphere Formation and Cell Survival in Epithelial Cancer Stem Cells.
Alberti L; Losi L; Leyvraz S; Benhattar J
PLoS One; 2015; 10(7):e0132977. PubMed ID: 26185996
[TBL] [Abstract][Full Text] [Related]
13. WNT5A signaling impairs breast cancer cell migration and invasion via mechanisms independent of the epithelial-mesenchymal transition.
Prasad CP; Chaurasiya SK; Guilmain W; Andersson T
J Exp Clin Cancer Res; 2016 Sep; 35(1):144. PubMed ID: 27623766
[TBL] [Abstract][Full Text] [Related]
14. Resveratrol suppresses migration, invasion and stemness of human breast cancer cells by interfering with tumor-stromal cross-talk.
Suh J; Kim DH; Surh YJ
Arch Biochem Biophys; 2018 Apr; 643():62-71. PubMed ID: 29477771
[TBL] [Abstract][Full Text] [Related]
15. A novel miR-34a target, protein kinase D1, stimulates cancer stemness and drug resistance through GSK3/β-catenin signaling in breast cancer.
Kim do Y; Park EY; Chang E; Kang HG; Koo Y; Lee EJ; Ko JY; Kong HK; Chun KH; Park JH
Oncotarget; 2016 Mar; 7(12):14791-802. PubMed ID: 26895471
[TBL] [Abstract][Full Text] [Related]
16. CD74 interacts with CD44 and enhances tumorigenesis and metastasis via RHOA-mediated cofilin phosphorylation in human breast cancer cells.
Liu Z; Chu S; Yao S; Li Y; Fan S; Sun X; Su L; Liu X
Oncotarget; 2016 Oct; 7(42):68303-68313. PubMed ID: 27626171
[TBL] [Abstract][Full Text] [Related]
17. CD44ICD promotes breast cancer stemness via PFKFB4-mediated glucose metabolism.
Gao R; Li D; Xun J; Zhou W; Li J; Wang J; Liu C; Li X; Shen W; Qiao H; Stupack DG; Luo N
Theranostics; 2018; 8(22):6248-6262. PubMed ID: 30613295
[TBL] [Abstract][Full Text] [Related]
18. Crosstalk between Raf-MEK-ERK and PI3K-Akt-GSK3β signaling networks promotes chemoresistance, invasion/migration and stemness via expression of CD44 variants (v4 and v6) in oral cancer.
Kashyap T; Pramanik KK; Nath N; Mishra P; Singh AK; Nagini S; Rana A; Mishra R
Oral Oncol; 2018 Nov; 86():234-243. PubMed ID: 30409306
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the stemness potency of
Yousefnia S; Ghaedi K; Seyed Forootan F; Nasr Esfahani MH
Tumour Biol; 2019 Aug; 41(8):1010428319869101. PubMed ID: 31423948
[TBL] [Abstract][Full Text] [Related]
20. GLI3 knockdown decreases stemness, cell proliferation and invasion in oral squamous cell carcinoma.
Rodrigues MFSD; Miguita L; De Andrade NP; Heguedusch D; Rodini CO; Moyses RA; Toporcov TN; Gama RR; Tajara EE; Nunes FD
Int J Oncol; 2018 Dec; 53(6):2458-2472. PubMed ID: 30272273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
